Founded in 2011, Omni Pharmaceuticals (OMNI) is a high-tech innovative pharmaceutical company focused on the development of highly difficult drug delivery technologies. It is currently engaged in the research and development and industrialization of inhaled preparations, and has a strong technical advantage over the top pharmaceutical companies in Europe and America.
Since its establishment, the company has won the support of well-known investment institutions at home and abroad, and has attracted the participation of multinational executives to form a team of internationally advanced respiratory drug delivery development and industrialization talents.
Contact
Room 802, Block B, Chamtime Plaza, Pudong New Area, Shanghai, China
Tel: +86 21 51388239
Website: http://www.omni-pharma.com/
Email: BD@omni-pharma.com
Kai Zhang, founder and chairman, and Sonia Wang, CEO, of Chinese respiratory technology specialist Omni Pharmaceuticals, discuss the respiratory market in China, how Omni plans to introduce four respiratory drugs…
Kai Zhang, founder and chairman, and Sonia Wang, CEO, of Chinese respiratory technology specialist Omni Pharmaceuticals, discuss the respiratory market in China, how Omni plans to introduce four respiratory drugs…
Carolin Hillebrand, country manager of Neurim Pharmaceuticals Switzerland, a neuroscience specialty company, discusses the launch of their lead product Circadin, the only IP-protected product providing a prolonged release formulation of…
”The Mon Trésor Smart City will cater to the business needs of the global healthcare and life sciences sector as no other smart city can.” The Head of Property Development…
See our Cookie Privacy Policy Here
